Efficacy of Early Continuous Infusion of HSS on the Neurological Outcome at 6 Months in TBI Patients.

NCT07319208 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

760

Enrollment

OTHER

Sponsor class

Conditions

TBI Traumatic Brain Injury

Interventions

DRUG: Hypertonic saline solution

Sponsor

Nantes University Hospital